Lexaria Bioscience Corp. (NASDAQ:LEXXW) Short Interest Down 41.2% in February

Lexaria Bioscience Corp. (NASDAQ:LEXXWGet Free Report) was the target of a large drop in short interest in the month of February. As of February 28th, there was short interest totalling 2,000 shares, a drop of 41.2% from the February 13th total of 3,400 shares. Based on an average trading volume of 9,100 shares, the short-interest ratio is presently 0.2 days.

Lexaria Bioscience Stock Performance

Shares of NASDAQ LEXXW traded up $0.06 during midday trading on Friday, hitting $0.26. 11,005 shares of the company’s stock were exchanged, compared to its average volume of 13,173. Lexaria Bioscience has a twelve month low of $0.16 and a twelve month high of $2.07. The stock’s 50 day moving average price is $0.39 and its 200-day moving average price is $0.69.

About Lexaria Bioscience

(Get Free Report)

Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods.

Featured Stories

Receive News & Ratings for Lexaria Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lexaria Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.